NCT06834204Enrolling by invitation
Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
ACCESS-PC: Advancing Care Coordination to Enhance Shared Care for Complex Cancer Survivors in Primary Care.
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Brief summary (registry, in English)
The purpose of this randomized clinical trial is to learn if 'complex' cancer patients who receive care guided by a health system intervention, Primary Care Connect (PC2) have their risks of cardiovascular disease (CVD) managed better than those who receive usual care. This study focuses on "complex" cancer survivors who have higher CVD risk when diagnosed with cancer because they also have had a diagnosis of 1 or more chronic conditions (e.g., hypertension, diabetes, and/or hyperlipidemia) requiring medication management. This study also aims to learn about the ease of implementing the health system intervention from the perspectives of cancer teams, primary care teams, and complex cancer patients. The main questions the study aims to answer are: * Do patients enrolled in the PC2 arm remain connected to their primary care teams during active cancer treatment for chronic disease management compared to patients in usual care? * Do patients enrolled in the PC2 arm have better management of their chronic conditions during active cancer treatment compared to patients in usual care? * How do the care team and patients experience this change in care delivery related to their work and care experiences? This study will compare complex cancer survivors who receive care according to the PC2 intervention to usual care to see if PC2 works to improve cardiovascular risk management. Participants will: * receive educational materials about the study upon enrollment * complete on-line or written surveys at 4 times * Visit the clinic for check ups and test related to the study 4 times
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 266 (estimated)
- First submitted
- 4 Feb 2025
- Start date
- 24 Apr 2026
- Primary completion date
- 1 Jul 2028
- Lead sponsor
- Rutgers, The State University of New Jersey
- Diseases
- Prostate cancer, Familial hypercholesterolaemia, Bladder cancer, High blood pressure, Endometrial cancer, Type 1 diabetes
- NCT number
- NCT06834204
What you commit to
- Study type: Interventional
- Planned participants: 266
- From 24 Apr 2026 to the primary completion date, 1 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- had myocardial infarction or stroke within the previous 1 year;
Other illness
- or do not speak English or Spanish. Patients whose cancer progresses to metastatic disease during the course of the 18-month trial will be allowed to continue to participate unless they voluntarily withdraw
Lab values
- have heart failure with an ejection fraction \<30%; (3) have stage IV-V chronic kidney disease (eGFR \<30);
Who the study is looking for
- diagnosed with any of the following cancers \[Stage I-III\]: breast, prostate, urinary bladder, and endometrial in the past 6 months;
- being treated for cancer with curative intent;
- had initial patient visit at the cancer center in the last 3 months;
- are being treated for cancer with curative intent at the Rutgers Cancer Institute of New Jersey
- have ≥1 CVD risk factor (hypertension, hyperlipidemia or type II diabetes) prior to cancer diagnosis that requires medication management;
- currently receiving care from a primary care provider;
- Speak English or Spanish
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rutgers Cancer Institute Coordinator of this site? Confirm its status | New Brunswick | United States | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.